Reverse the trajectory of heart failure with SSO₂, the next frontier in STEMI

Reduce heart damage and improve ventricular function with TherOx® SuperSaturated Oxygen (SSO₂) Therapy, the first FDA-approved, catheter-based therapy to safely and effectively reduce infarct size by 26% in randomized control trials.1 It delivers high levels of dissolved oxygen to the heart without affecting door-to-balloon time.

Contact a product expert

Restore microvascular flow and reduce myocardial damage

Despite successful percutaneous coronary intervention (PCI), many patients with STEMI still go on to develop heart failure. And microvascular obstruction is strongly associated with hospitalization and mortality within one year. SSO₂ Therapy has been shown to reduce endothelial swelling and restore microvascular flow, leading to reductions in infarct size.1, 2

Lower patient risks and minimize myocardial damage

Harness the power of SSO₂ Therapy to decrease the risks of heart failure and hospitalization in your patients. The TherOx SSO₂ Therapy closed-loop system is simple to set up and easy to use. The one-time 60-minute infusion of superoxygenated blood minimizes myocardial damage and lowers the risk of future complications.

HELPFUL RESOURCES

Understand the SSO2 Therapy dual mechanism of action

SSO₂ Therapy provides an infusion of superoxygenated blood with a pO₂ level of 1,000 mmHg, about 7 to 10 times higher than normal arterial blood. The therapy can reverse capillary edema, nurturing heart tissue with oxygenated blood.

Learn More

Reduce infarct size

Studies show SSO₂ Therapy creates a 26% relative infarct size reduction and improvement of left ventricular function in LAD STEMI.1

Lower the risk of heart failure and mortality

SSO₂ Therapy has been associated with a lower one-year rate of all-cause mortality or new-onset heart failure.2, 3

Learn More

1 Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT), Journal: Journal of the American College of Cardiology, : 2007, ISSN: 0735-1097

2 https://doi.org/10.1016/j.jcin/2023.08.001

3 https://doi.org/10.1002/ccd.29090

Find your solution

From state-of-the-art medical devices to innovative software, we’ve designed our solutions to empower you to save more lives. Find out how ZOLL solutions can support your clinical team.

Connect with an expert